Meme Kanseri Hastalarında hTERT Gen Ekspresyonunun Klinikopatolojik Önemi
Abstract
Keywords
References
- Zhang J, Tian Q, Zhang M, Wang H, Wu L, Yang J. Immune-related biomarkers in triple-negative breast cancer. Breast Cancer [Internet]. 2021 Apr 9; Available from: https://link.springer.com/10.1007/s12282-021-01247-8
- Elsers D, Temerik DF, Attia AM, Hadia A, Hussien MT. Prognostic role of ALK-1 and h-TERT expression in glioblastoma multiforme: correlation with ALK gene alterations. J Pathol Transl Med [Internet]. 2021 May 11; Available from: http://www.ncbi.nlm.nih.gov/pubmed/33966367
- Bieche I, Nogues C, Paradis V, Olivi M, Bedossa P, Lidereau R, et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res. 2000; 6(2): 452-9.
- Zhang J, Tian Q, Zhang M, Wang H, Wu L, Yang J. Immune-related biomarkers in triple-negative breast cancer. 1994; 266(5193): 2011-5.
- Buseman CM, Wright WE, Shay JW. Is telomerase a viable target in cancer? Mutat Res. 2012; 730(1-2): 90-7.
- Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996; 18(2): 173-9.
- Low KC, Tergaonkar V. Telomerase: central regulator of all of the hallmarks of cancer. Trends Biochem Sci. 2013; 38(9): 426-34.
- Wang K, Wang R-L, Liu J-J, Zhou J, Li X, Hu W-W, et al. The prognostic significance of hTERT overexpression in cancers: A systematic review and meta-analysis. Medicine (Baltimore). 2018; 97(35): e11794.
Details
Primary Language
Turkish
Subjects
Clinical Sciences
Journal Section
Research Article
Authors
Ebubekir Dirican
0000-0003-2220-4306
Türkiye
Burak Kankaya
This is me
0000-0002-5451-7166
Türkiye
Zeynep Tatar
This is me
0000-0003-2783-5131
Türkiye
Publication Date
January 14, 2022
Submission Date
April 12, 2021
Acceptance Date
August 6, 2021
Published in Issue
Year 2022 Volume: 12 Number: 1